Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) in the real-world setting

H. T. van der Galien, M. Hoogendoorn, R. E. Kibbelaar, T. van Meerten, R. S. van Rijn*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

5 Citations (Scopus)
Original languageEnglish
Pages (from-to)151-152
Number of pages2
JournalAnnals of Oncology
Issue number1
Publication statusPublished - Jan-2019


  • Humans
  • Lymphoma, Large B-Cell, Diffuse
  • Progression-Free Survival
  • Randomized Controlled Trials as Topic
  • Rituximab

Cite this